FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to neurology and gerontology, and can be used for treating Alzheimer's disease. Method involves using a therapeutic composition containing 1.0-4.0 g of pea albumin (legumelin) dissolved in 150 ml of water, 3 times a day; the course length is 90 days.
EFFECT: using the invention enables improving the cognitive function according to the ADAS-Cog scale, reducing the total cholesterol and low-density lipoprotein levels in the blood plasma.
1 cl, 1 tbl, 1 ex
